Inhibition studies using mannose-rich competitive inhibitors demonstrated a significant reduction in ZIKV infection in DC-SIGN-expressing cells, suggesting that high-mannose N154 glycans are crucial for interaction with C-type lectin receptors such as DC-SIGN [45]. The gene discussed is CD209; the disease is Zika virus infectious disease.